4,071 results on '"Kim, Sung Hyun"'
Search Results
202. Development of Crosslinked PEI Solid Adsorbents for CO2 Capture
203. Exploration of the metal coordination region of concanavalin A for its interaction with human norovirus
204. Contralateral Hemispheric Brain Atrophy After Primary Intracerebral Hemorrhage
205. Stochastic stability and stabilization conditions of semi-Markovian jump systems with mode transition-dependent sojourn-time distributions
206. [formula omitted] control of Markovian jump LPV systems with measurement noises: Application to a DC-motor device with voltage fluctuations
207. Surgical Treatment of Traumatic Intracranial Aneurysms: Experiences at a Single Center over 30 Years
208. Correct Plane of the Sylvian Vein Dissection for Middle Cerebral Artery Aneurysm Using Indocyanine Green Videoangiography
209. Volumetric lung nodule segmentation using adaptive ROI with multi-view residual learning
210. Anti-inflammatory effects of a methanol extract of Dictamnus dasycarpus Turcz. root bark on imiquimod-induced psoriasis
211. Efficiency Improvement of Energy Harvesting Device Using Light Pressure Through Plasmon Coupling at the Interface Between Grained Ag Layer and Au Nanoparticles.
212. Simultaneous control of mechanical strength and hierarchical structure in freeze‐casted porous alumina by two‐step sintering.
213. Optical Measurement of Synaptic Vesicle Fusion and Its Inhibition by Inositol Pyrophosphate in Primary Cultured Hippocampal Neurons
214. Enhancing thermoelectric performance of single-walled carbon nanotube/reduced graphene oxide composites with small organic molecules as a novel additive.
215. Diversity of Cladosporium (Cladosporiales, Cladosporiaceae) species in marine environments and report on five new species
216. Thermal change in a resin block during motorized and manual implant placement
217. Bortezomib prevents ovariectomy-induced osteoporosis in mice by inhibiting osteoclast differentiation
218. Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients
219. Interference-based optical measurement of fluidic flow in a hollow-core fiber
220. Eine Allegorie auf die Zeit der frühen Weimarer Republik - Dr. Mabuse, der Spieler(1922) von Fritz Lang
221. Distribution of antibiotic resistance gene against Streptococcus parauberis isolated from cultured olive flounder (Paralichthys olivaceus) in Jeju, South Korea
222. Rhein Induces Oral Cancer Cell Apoptosis and ROS via Suppresse AKT/mTOR Signaling Pathway In Vitro and In Vivo
223. Investigation of contact formation mechanism and application of copper-based front contact paste for crystalline silicon solar cells
224. A Study on the Complex Charging Station Strategy Focusing on Brand Experience(BX)
225. Supplementary Table Legend from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
226. Supplementary Table 1 from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
227. Supplementary Figure 1 from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
228. Supplementary Figure 2 from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
229. Data from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
230. Supplementary Figure Legend from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
231. Supplementary Methods, Supplementary Figure Legends, Supplementary Table from Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
232. Supplementary Figure 1C from Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
233. Supplementary Data from Prediction of Recurrence-Free Survival in Postoperative Non–Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression
234. Supplementary Figure 3B from Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
235. Supplementary Figure 2 from Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
236. Data from Prediction of Recurrence-Free Survival in Postoperative Non–Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression
237. Supplemental Figure 5 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
238. Data from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
239. Supplemental Table 1 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
240. Supplemental Figure 2 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
241. Supplemental Figure 10 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
242. Supplemental Figure 4 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
243. Supplemental Figure 9 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
244. Supplemental Figure 3 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
245. Supplemental Figure 6 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
246. Supplemental Figure Legend from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
247. Supplemental Materials and Methods from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
248. Supplemental Figure 8 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
249. Supplemental Figure 7 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
250. L-type Ca 2+ channels mediate regulation of glutamate release by subthreshold potential changes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.